Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$5.96M Sell
44,979
-46,335
-51% -$5.71M 0.16% 113
2023
Q4
$9.98M Buy
91,314
+21,922
+32% +$2.28M 0.2% 107
2023
Q3
$7.15M Buy
69,392
+23,550
+51% +$2.54M 0.16% 138
2023
Q2
$5.29M Sell
45,842
-6,790
-13% -$771K 0.12% 135
2023
Q1
$5.6M Sell
52,632
-1,491
-3% -$161K 0.14% 134
2022
Q4
$6.01M Sell
54,123
-26,223
-33% -$2.68M 0.14% 132
2022
Q3
$6.92M Buy
80,346
+27,219
+51% +$2.43M 0.14% 151
2022
Q2
$4.84M Buy
53,127
+36,730
+224% +$3.26M 0.11% 149
2022
Q1
$1.26M Sell
16,397
-2,524
-13% -$199K 0.04% 209
2021
Q4
$1.45M Buy
+18,921
New +$1.51M 0.06% 171

Other funds holding MRK

Connectus Wealth's MRK Position: Q1 2024 in Review

Connectus Wealth reduced its Merck (MRK) stake by 51% in Q1 2024, selling an estimated $5.71M and leaving 44,979 shares worth $5.96M. The position accounts for 0.16% of the portfolio, ranked #113.

Connectus Wealth first reported a position in MRK in Q4 2021 and has held it in 10 quarters since. The position peaked at $9.98M in Q4 2023. 3,535 funds tracked by Wall St. Rank hold MRK as of Q1 2024.

  • Connectus Wealth held 44,979 shares of Merck worth $5.96M as of Q1 2024.
  • Connectus Wealth sold 46,335 Merck shares in Q1 2024, an estimated $5.71M.
  • Merck made up 0.16% of Connectus Wealth's portfolio in Q1 2024, its #113 holding.
  • Connectus Wealth first reported a position in Merck in Q4 2021 and has held it in 10 quarters since.
  • Connectus Wealth's Merck position peaked at $9.98M in Q4 2023.
  • 3,535 funds tracked by Wall St. Rank held Merck as of Q1 2024.

Based on Connectus Wealth's 13F filing for Q1 2024, filed 14 May 2024.